Home/Filings/4/0001127602-25-002336
4//SEC Filing

Chattopadhyay Sanat 4

Accession 0001127602-25-002336

CIK 0000310158other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 6:09 PM ET

Size

7.7 KB

Accession

0001127602-25-002336

Insider Transaction Report

Form 4
Period: 2025-01-27
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Transactions
  • Award

    Common Stock

    2025-01-27$97.94/sh+28,136$2,755,64078,758 total
Holdings
  • Common Stock

    (indirect: By GRAT 2023)
    46,995
  • Common Stock

    (indirect: By GRAT 2024)
    33,000
  • Common Stock

    (indirect: By GRAT 2022)
    26,575
Footnotes (4)
  • [F1]Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024.
  • [F2]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2022 Grantor Retained Annuity Trust.
  • [F3]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2023 Grantor Retained Annuity Trust.
  • [F4]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2024 Grantor Retained Annuity Trust.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001670690

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:09 PM ET
Size
7.7 KB